Kiniksa Pharmaceuticals Intern — institutional ownership

1 funds reported holding Kiniksa Pharmaceuticals Intern in their latest 13F filings, worth $40.0K in total (CUSIP G5269C101).

Largest holders

1. HARBOR CAPITAL ADVISORS, INC. — $40.0K